InMed Pharmaceuticals Inc. (INM) Insider Trading

Over the last 3 months, INM insiders made 20 open-market buys and 0 sales, a net purchase of $813K (SEC Form 4).

Insider Activity

Sentiment
100/100
Buys (3m)
20
Sells (3m)
0
Net (3m)
$813.3K
Insiders buying
Insider trades by month Buys Sells
Jan
Apr
Feb
Aug
May
Jun
Context3-month price +71.7%
DateInsiderTypeSharesPrice
Jun 10, 2026Vivo Opportunity, LLC10 percent ownerBuy14,838$1.55
Jun 10, 2026Vivo Opportunity, LLC10 percent ownerBuy1,632$1.57
Jun 10, 2026Vivo Opportunity, LLC10 percent ownerBuy16,164$1.57
Jun 10, 2026Vivo Opportunity, LLC10 percent ownerBuy3,118$1.69
Jun 10, 2026Vivo Opportunity, LLC10 percent ownerBuy30,882$1.69
Jun 10, 2026Vivo Opportunity, LLC10 percent ownerBuy5,154$1.56
Jun 10, 2026Vivo Opportunity, LLC10 percent ownerBuy51,056$1.56
Jun 10, 2026Vivo Opportunity, LLC10 percent ownerBuy2,982$1.52
Jun 10, 2026Vivo Opportunity, LLC10 percent ownerBuy29,518$1.52
Jun 10, 2026Vivo Opportunity, LLC10 percent ownerBuy5,045$1.57
Jun 10, 2026Vivo Opportunity, LLC10 percent ownerBuy49,966$1.57
Jun 10, 2026Vivo Opportunity, LLC10 percent ownerBuy618$1.57
Jun 10, 2026Vivo Opportunity, LLC10 percent ownerBuy6,125$1.57
Jun 10, 2026Vivo Opportunity, LLC10 percent ownerBuy714$1.55
Jun 10, 2026Vivo Opportunity, LLC10 percent ownerBuy7,069$1.55
Jun 10, 2026Vivo Opportunity, LLC10 percent ownerBuy2,095$1.52
Jun 10, 2026Vivo Opportunity, LLC10 percent ownerBuy20,753$1.52
Jun 10, 2026Vivo Opportunity, LLC10 percent ownerBuy1,498$1.55
May 21, 2026ADAR1 Capital Management, LLC10 percent ownerBuy68,551$1.60
May 21, 2026ADAR1 Capital Management, LLC10 percent ownerBuy200,000$1.56
Dec 19, 2025ADAMS ERIC Adirector, officer: President & CEOGrant35,000$1.29
Dec 19, 2025HULL ANDREWdirectorGrant1,750$1.29
Dec 19, 2025Lemerond NicoledirectorGrant1,750$1.29
Dec 19, 2025Klompas Neil AdirectorGrant1,750$1.29
Dec 19, 2025Johnson Shane Aaronofficer: Sr VP & General ManagerGrant8,500$1.29
Dec 19, 2025Jagpal Nettaofficer: Chief Financial OfficerGrant18,000$1.29
Dec 19, 2025WOUDENBERG MICHAELofficer: Chief Operating OfficerGrant18,000$1.29
Dec 19, 2025Bathery John StevendirectorGrant1,750$1.29
Dec 19, 2025HSU ERIC Cofficer: Sr. VP, Pre-Clinical Res/DevGrant13,000$1.29
Oct 21, 2025Klompas Neil AdirectorGrant3,500$2.10

Source: INM SEC Form 4 filings, latest Jun 10, 2026. For informational purposes only — not investment advice.

← Back to INM overview (price, financials, earnings)